Integrated Core Strategies (Asia) Pte. Ltd. 13D/13G Filings for C4 Therapeutics, Inc. (CCCC)

Integrated Core Strategies (Asia) Pte. Ltd. 13D and 13G filings for C4 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-07-25
4:40 pm
Purchase
2023-07-1913GC4 Therapeutics, Inc.
CCCC
Integrated Core Strategies (Asia) Pte. Ltd.2,370,504
4.800%
2,370,504increase
(New Position)
Filing